To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 23 December 2014 (HL3669), what grant applications were made to the National Institute for Health and Care Excellence over the last ten years for mesothelioma research, including in each case the specific types of grant application; which were successful and which unsuccessful; and what were the applying organisation and the individual values of each successful and unsuccessful grant application.
Answered on
23 February 2015
Grant applications for mesothelioma research are handled by the National Institute for Health Research (NIHR).
Details of applications relating to mesothelioma submitted to research programmes managed by NIHR in the last eight years (2006-07 to 2013-14) are shown in the following tables.
Successful applications
Programme | Organisation | Amount awarded |
Efficacy and Mechanism Evaluation, research-led funding stream | University of Birmingham | Subject to contract |
Health Technology Assessment | University of Bristol | £635,413 |
Research for Patient Benefit | North Bristol NHS Trust | £238,606 |
Research for Patient Benefit | The Christie NHS Foundation Trust | £243,211 |
Unsuccessful applications
Programme | Amount requested |
Efficacy and Mechanism Evaluation, research-led funding stream | £1,819,907 |
Health Technology Assessment | £480,000 |
Health Technology Assessment | £1,200,000 |
Health Technology Assessment | £1,206,118 |
Research Fellowships | £791,206 |
Research Fellowships | £255,221 |
Research for Patient Benefit | £250,000 |
Research for Patient Benefit | £171,476 |
Research for Patient Benefit | £236,079 |
Research for Patient Benefit | £236,305 |
Research Professorships | £1,228,874 |
The Efficacy and Mechanism Evaluation programme researcher-led funding stream is managed by NIHR and funded by the Medical Research Council.
Applications are submitted to NIHR in confidence and we are unable to disclose further details of unsuccessful applications.
The NIHR was established in April 2006. No applications relating to mesothelioma were submitted to national National Health Service research and development programmes in 2004-05 or 2005-06.